Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Cancer (NSCLC) With Brain Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07491211
What this trial is testing

Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)Brain Metastases From Non-small Cell Lung Cancer (NSCLC)Osimertinib+1 more
Fudan University 300
Testing effectiveness (Phase 2)Looking for participantsNCT05786924
What this trial is testing

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Who this might be right for
Non-small Cell Lung CancerHistiocytic NeoplasmHistiocytosis+29 more
Institut de Recherches Internationales Servier 554
Testing effectiveness (Phase 2)Study completedNCT03046992
What this trial is testing

Clinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLC

Who this might be right for
EGFR Gene Mutation
Yuhan Corporation 224
Not applicableActive Not RecruitingNCT06557187
What this trial is testing

Hippocampus-Avoidance Whole-Brain Radiation Therapy With Simultaneous Integrated Boost for BMs of NSCLC

Who this might be right for
Brain MetastasesNon-small Cell Lung Cancer
Yatian Liu 40
Early research (Phase 1)WithdrawnNCT00738335
What this trial is testing

Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain Metastases

Who this might be right for
Lung CancerMetastatic Cancer
University of California, San Francisco
Not applicableTemporarily pausedNCT04835025
What this trial is testing

Radiotherapy Combined With Immunotherapy for Brain Metastases of Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Tongji Hospital 200
Testing effectiveness (Phase 2)Study completedNCT04507217
What this trial is testing

Tislelizumab Combined With Pemetrexed/ Carboplatin in Patients With Brain Metastases of Non-squamous NSCLC

Who this might be right for
NSCLC Stage IVBrain MetastasesPD-1 Antibody
Sun Yat-sen University 36
Post-approval studies (Phase 4)Active Not RecruitingNCT06282874
What this trial is testing

Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases

Who this might be right for
Carcinoma, Non-Small-Cell LungBrain MetastasesLeptomeningeal Metastasis
Guangdong Association of Clinical Trials 41
Testing effectiveness (Phase 2)WithdrawnNCT04460729
What this trial is testing

A Phase II, Open-Label, Multicenter Study of Capmatinib in Subjects With MET Exon 14 Skipping Mutation Positive, Advanced, NSCLC With Brain Metastases

Who this might be right for
Non-small Cell Lung Carcinoma (NSCLC)
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT04829019
What this trial is testing

Neurocognition in NSCLC Patients Treated With Osimertinib or Osimertinib + WBI

Who this might be right for
Neurocognitive
Sun Yat-sen University 88
Testing effectiveness (Phase 2)UnknownNCT05326425
What this trial is testing

Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR TKI.

Who this might be right for
Lung Neoplasms
Jin Hyoung Kang 40
Large-scale testing (Phase 3)Ended earlyNCT00096265
What this trial is testing

Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Malignant Neoplasm in the BrainRecurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer AJCC v7
National Cancer Institute (NCI) 126
Testing effectiveness (Phase 2)Looking for participantsNCT07304739
What this trial is testing

Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal Metastases

Who this might be right for
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableWithdrawnNCT01731704
What this trial is testing

Neurocognitive Outcomes In Patients Treated With Radiotherapy For Five Or More Brain Metastases

Who this might be right for
Brain Metastases
University of California, San Francisco
Early research (Phase 1)Looking for participantsNCT06253871
What this trial is testing

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Who this might be right for
HER2 Mutation-Related TumorsHER2HER2-positive Breast Cancer+10 more
Iambic Therapeutics, Inc 383
Testing effectiveness (Phase 2)Study completedNCT00312728
What this trial is testing

Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Treated Brain Metastases Due to Non-Squamous NSCLC (PASSPORT)

Who this might be right for
Non-Small Cell Lung CancerBrain Neoplasms
Genentech, Inc. 115
Testing effectiveness (Phase 2)UnknownNCT02655536
What this trial is testing

Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II Trial

Who this might be right for
Carcinoma, Non-Small-Cell LungBrain Neoplasms
National Taiwan University Hospital 109
Testing effectiveness (Phase 2)Study completedNCT03497767
What this trial is testing

A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases

Who this might be right for
Metastatic Non Small Cell Lung Cancer
Trans Tasman Radiation Oncology Group 40
Testing effectiveness (Phase 2)Ended earlyNCT00872482
What this trial is testing

Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases

Who this might be right for
Metastatic Non-Small Cell Lung Cancer
YM BioSciences 21
Large-scale testing (Phase 3)UnknownNCT01158170
What this trial is testing

Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)

Who this might be right for
Non-small Cell Lung Cancer
Zhejiang Cancer Hospital 200
Next Page